Developing new drugs is no easy feat. As much as 95 percent of new compounds fail along the path to becoming clinically available. Attrition is especially high for drugs treating the central nervous system. The ones that do succeed rack up an average cost of $1.8 billion. So researchers are increasingly turning to the bottles already on the shelf. Proved safe for human consumption and often understood at a molecular level, today's familiar pills might just be tomorrow's medical discovery. Sometimes one man's side effect is another man's cure.
iSTOCKPHOTO (people); SVETLANA ALYUK iStockphoto (mice)
See what we're tweeting about
3 Comments
Add CommentWithdrawal symptoms from marijuana? Hmpf.
Reply | Report Abuse | Link to thisI think they should try it on opiate or nicotine withdrawals before getting too excited.
I have also tried Propranolol. <a href="http://www.amanevitzmd.com/">New York psychiatrist</> recommended that I try it before giving presentations at work.
Reply | Report Abuse | Link to this<a href="http://sachscenter.com/dr-george-sachs/">Dr Sachs</a> referred me to a psychiatrist who has uses Gabapentin for addiction treatment
Reply | Report Abuse | Link to this